Exploring new ways to block protein interactions in cancer treatment
Covalent PD1 Antagonists: Discovery of Protein-Protein Interaction (PPI) Inhibitors in Cancer Immunotherapy
This study is exploring new ways to block certain protein interactions that help cancer grow, using special tools and techniques, with the hope of creating better treatments that could help patients respond more effectively to cancer therapy.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Florida Atlantic University NIH-funded |
| Lab location | 1 site (Boca Raton, United States) |
| Project ID | NIH-10994616 on NIH RePORTER |
What this research studies
This research investigates innovative methods to inhibit protein-protein interactions (PPIs) that are crucial in cancer biology. By utilizing advanced proteomic tools and gene-editing techniques, the project aims to develop novel PPI inhibitors using β-hairpin peptides that mimic antibody structures. This approach seeks to enhance the specificity and effectiveness of cancer immunotherapy by targeting specific interactions that contribute to tumor growth and immune evasion. Patients may benefit from new therapeutic options that could improve their response to cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancer who may benefit from new immunotherapy treatments.
Not a fit: Patients with non-cancerous conditions or those who do not respond to immunotherapy may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer immunotherapies that enhance the body's ability to fight tumors.
How similar studies have performed: Other research has shown promise in targeting protein-protein interactions for cancer treatment, indicating that this approach could be a viable strategy.
Where this research is happening
Boca Raton, United States
- Florida Atlantic University — Boca Raton, United States (Active)
Researchers
- Principal investigator: Roche, Stephane P — Florida Atlantic University
- Study coordinator: Roche, Stephane P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.